首页 | 本学科首页   官方微博 | 高级检索  
     


Randomized,double-blind,placebo-controlled,international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease
Authors:Topol Eric J,Easton Donald,Harrington Robert A,Amarenco Pierre,Califf Robert M,Graffagnino Carmen,Davis Stephen,Diener Hans-Christophe,Ferguson James,Fitzgerald Desmond,Granett Jeffrey,Shuaib Ashfaq,Koudstaal Peter J,Theroux Pierre,Van de Werf Frans,Sigmon Kristina,Pieper Karen,Vallee Marc,Willerson James T  Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion Trial Investigators
Affiliation:Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. topole@ccf.org
Abstract:
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号